Invega



Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 22.8%
Schizophrenia 20.0%
Product Used For Unknown Indication 18.8%
Bipolar Disorder 8.9%
Schizophrenia, Paranoid Type 4.6%
Schizoaffective Disorder 4.2%
Psychotic Disorder 4.0%
Depression 3.6%
Anxiety 2.4%
Hypertension 1.3%
Insomnia 1.3%
Diabetes Mellitus 1.2%
Bipolar I Disorder 1.1%
Affective Disorder 1.0%
Ill-defined Disorder 0.9%
Attention Deficit/hyperactivity Disorder 0.9%
Sleep Disorder 0.8%
Schizophrenia, Disorganised Type 0.8%
Constipation 0.7%
Drug Therapy 0.7%
Weight Increased 16.2%
Galactorrhoea 10.9%
Tremor 7.0%
Extrapyramidal Disorder 5.1%
Tardive Dyskinesia 5.1%
Dystonia 4.9%
Suicide Attempt 4.7%
Drug Ineffective 4.6%
Tachycardia 4.4%
Somnolence 4.2%
Blood Prolactin Increased 4.1%
Wrong Technique In Drug Usage Process 3.7%
Rash 3.6%
Neuroleptic Malignant Syndrome 3.4%
Vomiting 3.3%
Psychotic Disorder 3.2%
Restlessness 3.0%
Treatment Noncompliance 2.9%
Sedation 2.8%
Suicidal Ideation 2.8%
Secondary
Schizophrenia 21.5%
Product Used For Unknown Indication 15.7%
Bipolar Disorder 9.9%
Schizophrenia, Paranoid Type 9.1%
Drug Use For Unknown Indication 7.1%
Psychotic Disorder 6.5%
Schizoaffective Disorder 5.4%
Depression 4.5%
Schizophrenia, Undifferentiated Type 2.9%
Anxiety 2.8%
Agitation 2.1%
Constipation 1.6%
Prophylaxis 1.5%
Attention Deficit/hyperactivity Disorder 1.5%
Insomnia 1.5%
Abnormal Behaviour 1.4%
Schizophrenia, Disorganised Type 1.4%
Diabetes Mellitus 1.3%
Personality Disorder 1.3%
Hypertension 1.2%
Weight Increased 19.6%
Galactorrhoea 7.4%
Tremor 6.3%
Drug Ineffective 5.2%
Weight Decreased 5.1%
Extrapyramidal Disorder 4.8%
Tardive Dyskinesia 4.7%
Off Label Use 4.5%
Agitation 4.4%
Sedation 4.1%
Neuroleptic Malignant Syndrome 3.8%
Psychotic Disorder 3.8%
Treatment Noncompliance 3.7%
Oedema Peripheral 3.6%
Suicide Attempt 3.6%
Hyperprolactinaemia 3.4%
Wrong Technique In Drug Usage Process 3.4%
Somnolence 3.0%
Schizophrenia 2.9%
Tachycardia 2.9%
Concomitant
Schizophrenia 21.4%
Product Used For Unknown Indication 18.5%
Bipolar Disorder 11.0%
Depression 8.5%
Schizoaffective Disorder 6.5%
Anxiety 4.9%
Psychotic Disorder 3.1%
Hepatitis C 2.7%
Drug Use For Unknown Indication 2.5%
Affective Disorder 2.4%
Hypertension 2.3%
Pain 2.3%
Schizophrenia, Paranoid Type 2.3%
Agitation 1.8%
Attention Deficit/hyperactivity Disorder 1.7%
Crohn's Disease 1.7%
Insomnia 1.7%
Bipolar I Disorder 1.6%
Asthma 1.5%
Diabetes Mellitus 1.4%
Weight Increased 20.3%
Schizophrenia 7.0%
Drug Ineffective 5.9%
Off Label Use 5.9%
Vomiting 5.9%
Suicidal Ideation 4.8%
Type 2 Diabetes Mellitus 4.8%
Granulocytopenia 4.3%
Psychotic Disorder 4.3%
Delirium 3.7%
Depression 3.7%
Drug Dose Omission 3.7%
Psychiatric Symptom 3.7%
White Blood Cell Count Increased 3.7%
Inappropriate Schedule Of Drug Administration 3.2%
Incorrect Dose Administered 3.2%
Leukopenia 3.2%
Rash 3.2%
Anxiety 2.7%
Drug Interaction 2.7%
Interacting
Hepatitis C 39.1%
Schizophrenia 26.1%
Drug Therapy 13.0%
Schizoaffective Disorder 8.7%
Bipolar Disorder 4.3%
Chronic Myeloid Leukaemia 4.3%
Product Used For Unknown Indication 4.3%
Drug Interaction 30.0%
Syncope 20.0%
Aspiration Bronchial 10.0%
Dehydration 10.0%
Insomnia 10.0%
Labelled Drug-food Interaction Medication Error 10.0%
Mania 10.0%